Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite Claude Bernard Lyon 1, Ens-Ecole Normale Superieure De Lyon, Centre National de la Recherche Scientifique (CNRS), Hospices Civils De Lyon
InventorsVincent Lotteau, Patrice Andre, Benoit De Chassey, Laurene Meyniel-Schicklin, Irene Pilar Castellanos
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and pharmaceutical compositions for the treatment of polyomavirus infections. In particular, the present invention relates to a method for treating a polyomavirus infection in a subject in need thereof comprising administering the subject with a therapeutically effective amount of gemcitabine.
Claims27
A method of treating a polyomavirus infection in a subject in need thereof comprising administering to the subject a therapeutically effective amount of gemcitabine or a gemcitabine derivative.
A method for the prophylactic treatment of a disease associated with polyomaviruses in a subject in need thereof comprising administering to the subject a therapeutically effective amount of gemcitabine.
Dependencies are inferred from the claim text.